Palo Alto Investors LP Pyxis Oncology, Inc. Call Options Transaction History
Palo Alto Investors LP
- $442 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PYXS
# of Institutions
74Shares Held
22.9MCall Options Held
0Put Options Held
0-
Laurion Capital Management LP New York, NY3.63MShares$3.77 Million0.07% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.54MShares$3.68 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$2.9 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.5MShares$2.6 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$2.24 Million0.0% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $36.5M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...